NASDAQ:SELB

Selecta Biosciences (SELB) News Headlines

$2.36

+0.48 (+25.53%)

(As of 08/5/2022 12:00 AM ET)

Add

Compare

Today's Range: $1.89
▼
$2.54
50-Day Range: $0.77
▼
$2.36
52-Week Range: $0.65
▼
$4.70

Volume: 6.54 million shs
Average Volume: 1.65 million shs
Market Capitalization: $358.27 million

P/E Ratio: 236.00
Dividend Yield: N/A
Price Target: $5.33

Get Selecta Biosciences News Delivered to You Automatically

SELB Media Mentions By Week

SELB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SELB
News Sentiment
▼
0.90

0.34
▲
Average
Medical
News Sentiment

SELB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SELB Articles
This Week
▼
7

1
▲
SELB Articles
Average Week

Source

Source	Headline
	Selecta Biosciences (NASDAQ:SELB) Announces Earnings Results marketbeat.com - August 7 at 12:49 PM
	Selecta Biosciences, Inc's (SELB) CEO Carsten Brunn on Q2 2022 Results - Earnings Call Transcript seekingalpha.com - August 6 at 5:30 PM
	What Kind Of Investors Own Most Of Selecta Biosciences, Inc. (NASDAQ:SELB)? finance.yahoo.com - August 6 at 12:29 PM
	Selecta stock rises 13% on Q2 beat while revenue doubles seekingalpha.com - August 4 at 1:15 PM
	Selecta Biosciences, Inc. (SELB) Q2 Earnings and Revenues Surpass Estimates finance.yahoo.com - August 4 at 1:15 PM
	Selecta Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update finance.yahoo.com - August 4 at 8:15 AM
	Selecta Biosciences, Inc. (SELB) Upgraded to Strong Buy: Here's What You Should Know finance.yahoo.com - July 28 at 5:07 PM
	Selecta Biosciences to Host Conference Call and Webcast to Discuss Second Quarter 2022 Financial Results and Provide Business Update finance.yahoo.com - July 28 at 12:07 PM
	Analysts Set Selecta Biosciences, Inc. (NASDAQ:SELB) Price Target at $4.88 americanbankingnews.com - July 18 at 2:36 AM
	Strong week for Selecta Biosciences (NASDAQ:SELB) shareholders doesn't alleviate pain of five-year loss finance.yahoo.com - July 14 at 11:41 AM
	Vertex (VRTX) to Buy ViaCyte to Speed Up VX-880 Program finance.yahoo.com - July 12 at 9:38 AM

	Selecta Biosciences to Participate at the Guggenheim I&I Spotlight Series – Treg-based Therapies Conference finance.yahoo.com - July 6 at 2:40 PM
	Surface Oncology Appoints Carsten Brunn to Board of Directors finance.yahoo.com - June 29 at 10:34 AM
	Expert Ratings for Selecta Biosciences markets.businessinsider.com - June 21 at 11:51 AM
	BioMarin (BMRN) Stock Jumps 5.4%: Will It Continue to Soar? finance.yahoo.com - June 20 at 6:12 PM
	Some Analysts Just Cut Their Selecta Biosciences, Inc. (NASDAQ:SELB) Estimates finance.yahoo.com - June 14 at 9:59 AM
	Selecta Biosciences Announces Partnership Advancements and Clinical Trial Updates finance.yahoo.com - June 13 at 7:49 AM
	Why Wall Street Doubts This Biotech Penny Stock Will Be Delisted finance.yahoo.com - June 10 at 4:10 PM
	SVB Leerink Sees Over 600% Upside For This Penny Biotech Stock finance.yahoo.com - June 6 at 6:33 PM
	7 Cheap Biotech Stocks to Buy Now finance.yahoo.com - May 27 at 1:21 AM
	Selecta Biosciences to Participate at the H.C. Wainwright Global Investment Conference finance.yahoo.com - May 17 at 8:14 AM
	Could The Market Be Wrong About Selecta Biosciences, Inc. (NASDAQ:SELB) Given Its Attractive Financial Prospects? finance.yahoo.com - May 10 at 7:20 PM
	Needham Maintains Buy Rating for Selecta Biosciences: Here's What You Need To Know markets.businessinsider.com - May 6 at 1:19 PM
	Selecta Biosciences (SELB) CEO Carsten Brunn On Q1 2022 Results - Earnings Call Transcript seekingalpha.com - May 6 at 1:36 AM
	Selecta Biosciences Tops Q1 EPS by 34c in.investing.com - May 5 at 9:50 AM
	Selecta Biosciences Announces Six Presentations at the Upcoming 25th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) finance.yahoo.com - May 2 at 8:42 PM
	Selecta Biosciences to Host Conference Call and Webcast to Discuss First Quarter 2022 Financial Results and Provide Business Update finance.yahoo.com - April 28 at 10:13 AM
	Selecta Biosciences to raise $38.7M in stock and warrants offering seekingalpha.com - April 7 at 9:01 AM
	Selecta Biosciences Announces $38.7 Million Underwritten Offering finance.yahoo.com - April 6 at 11:00 PM
	Selecta Biosciences to Participate at the 21st Annual Needham Virtual Healthcare Conference finance.yahoo.com - April 4 at 10:32 AM
	Selecta Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update finance.yahoo.com - March 10 at 10:10 AM
	Selecta Biosciences Q4 2021 Earnings Preview seekingalpha.com - March 9 at 2:07 PM
	Earnings Preview: Selecta Biosciences benzinga.com - March 9 at 2:07 PM
	Selecta Biosciences to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2021 Financial Results and Provide Business Update finance.yahoo.com - March 3 at 12:08 PM

	Shareholders in Selecta Biosciences (NASDAQ:SELB) are in the red if they invested five years ago nasdaq.com - February 10 at 6:41 PM
	Selecta Biosciences to Participate at the SVB Leerink 11th Annual Global Healthcare Conference finance.yahoo.com - February 9 at 12:55 PM
	Selecta taps Ginkgo for deal worth up to $1.1B finance.yahoo.com - January 11 at 12:42 PM
	Selecta Biosciences and Ginkgo Bioworks Announce New Collaboration to Develop Next-Generation Gene Therapy Capsids finance.yahoo.com - January 10 at 8:51 AM
	Selecta Biosciences to Participate at the 2022 H.C. Wainwright BioConnect Conference finance.yahoo.com - January 5 at 9:11 AM
	Selecta Biosciences to Participate at the LifeSci Partners 11th Annual Corporate Access Event finance.yahoo.com - December 29 at 12:42 PM
	Thinking about buying stock in Galera Therapeutics, Terminix Global, Aeglea Bio Therapeutics, Alzamend Neuro, or Selecta Biosciences? benzinga.com - December 16 at 8:05 AM
	Carrie Cox Is The Independent Chairman of Selecta Biosciences, Inc. (NASDAQ:SELB) And They Just Picked Up 26% More Shares nasdaq.com - December 12 at 12:28 PM
	Trade Alert: The Independent Chairman Of Selecta Biosciences, Inc. (NASDAQ:SELB), Carrie Cox, Has Just Spent US$51k Buying 26% More Shares finance.yahoo.com - December 12 at 12:28 PM
	The Petri Dish: Selecta hit with clinical hold, Biogen loses patent appeal finance.yahoo.com - December 2 at 9:04 AM
	Selecta's Gene Therapy Trial For Genetic Metabolic Disorder Put On FDA Hold markets.businessinsider.com - November 26 at 8:59 AM
	Selecta Biosciences Provides Update on Phase 1/2 Clinical Trial of SEL-302 for the Treatment of Methylmalonic Acidemia finance.yahoo.com - November 24 at 7:10 PM
	Selecta Biosciences to Participate in Jefferies Virtual London Healthcare Conference finance.yahoo.com - November 11 at 9:26 AM
	Selecta Biosciences's Return On Capital Employed Insights benzinga.com - November 10 at 6:07 PM
	Selecta Biosciences, Inc. (SELB) Reports Q3 Loss, Tops Revenue Estimates finance.yahoo.com - November 9 at 3:13 PM
	Selecta Biosciences Reports Third Quarter 2021 Financial Results and Provides Business Update finance.yahoo.com - November 9 at 10:13 AM
	Selecta Biosciences Announces Top Line Data from the Phase I SEL-399 AAV Empty Capsid Study, Highlighting Potential Benefits of ImmTOR™ in Gene Therapy finance.yahoo.com - November 8 at 8:50 AM

Get Selecta Biosciences News Delivered to You Automatically

This page (NASDAQ:SELB) was last updated on 8/7/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms